Nevro Corp. Stock
Price
Target price
€8.65
€8.65
-5.980%
-0.55
-5.980%
€30.29
22.05.24 / Stuttgart Stock Exchange
WKN: A12EPL / Symbol: NVRO / Name: Nevro / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Nevro Corp. Stock
Heavy losses for Nevro Corp. today as the stock fell by -€0.550 (-5.980%).
Currently there is a rather positive sentiment for Nevro Corp. with 4 Buy predictions and 2 Sell predictions.
Based on the current price of 8.65 € the target price of 30 € shows a potential of 246.82% for Nevro Corp. which would more than double the current price.
Pros and Cons of Nevro Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nevro Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nevro Corp. | -5.980% | -10.363% | -26.695% | -65.400% | -56.313% | -92.967% | -83.115% |
| Orasure Tech | -0.440% | -8.571% | -10.040% | -7.819% | -39.866% | -42.623% | -39.598% |
| scPharmaceuticals | -3.300% | -15.789% | -16.981% | -65.490% | -38.783% | -24.786% | - |
| SI-BONE Inc | -2.290% | -6.569% | -11.111% | -46.667% | -32.632% | -50.388% | - |
Comments
Nevro Corp. (NYSE: NVRO) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $9.00 price target on the stock, down previously from $13.50.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Piper Sandler from $15.00 to $12.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Show more
Ratings data for NVRO provided by MarketBeat
News
Why Nevro Stock Lagged the Market on Thursday
Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter
